Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala)

BACKGROUND: Thiazolidinediones (TZDs) improves insulin sensitivity by activating the peroxisome proliferator-activated receptor γ (PPAR-g). We aimed to study any association between variation in bone biochemical markers and single nucleotide polymorphism (SNP) in PPAR-γ (Pro12Ala) and investigate if...

Descripción completa

Detalles Bibliográficos
Autores principales: Namvaran, Fatemeh, Rahimi-Moghaddam, Parvaneh, Azarpira, Negar, Dabbaghmanesh, Mohammad Hossien, Bakhshayeshkaram, Marzieh, Namvaran, Mohamad Mahdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793371/
https://www.ncbi.nlm.nih.gov/pubmed/24124423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793371/
https://www.ncbi.nlm.nih.gov/pubmed/24124423

Ejemplares similares